Clozapine

CAS 5786-21-0 18 FDA-DMF suppliersSmall Molecule

Overview

Clozapine is an atypical antipsychotic used for the treatment of resistant schizophrenia and for reducing the risk of suicidal behavior in people with schizophrenia. It works by blocking various neurotransmitter receptors in the brain, particularly serotonin and dopamine receptors.

API suppliers (14)

Suppliers of Clozapine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
  • SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTDChina1 active DMF
  • MEDICHEM SASpain1 active DMF
  • SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTDChina1 active DMF
  • CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
  • MEDICHEM SASpain1 active DMF
  • Wuxi STA Pharmaceutical Co., Ltd.China1 active DMF
  • CAMBREX PROFARMACO MILANO SRLItaly1 active DMF
  • COHANCE LIFESCIENCES LTD1 active DMF
  • Wuxi STA Pharmaceutical Co., Ltd.China1 active DMF
  • SHOUGUANG FUKANG PHARMACEUTICAL CO LTDChina1 active DMF
  • Arevipharma GmbHGermany
  • SANDOZ LTD PHARMACEUTICAL DIV CHEMICAL DEVELOPMENT
  • SELOC FRANCE

Patent & exclusivity (US)

Per the FDA Orange Book (34 approved US products), the latest listed US patent on Clozapine expires 30 Apr 2028. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

PsychiatryNeurologySchizophrenia

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.